Strapps Walter 4
4 · Gemini Therapeutics, Inc. /DE · Filed May 3, 2021
Insider Transaction Report
Form 4
Strapps Walter
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-29+9,000→ 9,000 totalExercise: $11.92Exp: 2031-04-29→ Common Stock (9,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of three years from the Grant Date, April 28, 2021, with 25% vesting on the Grant Date, and the remainder vesting in equal installments over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.